Laparoscopic radical prostatectomy experience in Vachira Phuket Hospital

Abstract

Background: The experience of laparoscopic radical prostatectomy guarantees accuracy, reduces complications, and enhances patient results. It also improves the effectiveness of treatment and speeds up recovery. For a few seconds, Patient outcomes are enhanced by accurate surgery and fewer problems, which are guaranteed by experience with laparoscopic radical prostatectomy. It also increases the efficacy of cancer treatment and encourages a quicker recovery.

Objective: To describe our experience in transperitoneal laparoscopic radical prostatectomy (LRP) and provide functional and oncological outcomes for the first 10 cases at our institution.

Materials and methods: A retrospective review from October 2020 to September 2021 identified 10 patients who underwent LRP for localized/locally advanced prostate cancer. The patient and tumor characteristics, pre-and postoperative prostate-specific antigen (PSA) levels, Gleason score, operative time, estimated blood loss, perioperative complications, and postoperative outcomes were recorded and analyzed.

Results: The median age of the patients was 64.7 years and the median preoperative PSA was 38.89 ng/mL. Five (50%) patients had PSA levels between 10 and 20 ng/mL and four (40%) patients had PSA levels >20 ng/mL. Four patients (40%) had Gleason scores <7 at the time of initial diagnosis. The median operative time was 254 minutes and the median estimated blood loss was 280 mL. Clavien-Dindo grade 3–5 complications were not observed. The median hospital stay and catheter time were 9 and 23 days, respectively. All patients achieved undetectable postoperative PSA after LRP at 12 weeks. Nine patients recovered continence completely at 3 months postoperatively.

Conclusion: LRP is the standard treatment for patients with non-metastatic prostate cancer. LRP is safe and feasible for the beginner urologist. The oncological and functional outcomes were similar to high-volume centers.